YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice

Alzheimer’s disease (AD) is the world’s most common form of dementia, in which aggregation of amyloid-β (Aβ) is the hallmark. Unfortunately, few medicines have succeeded to completely cure AD. Yangxue Qingnao (YXQN) is a Chinese traditional medicine, and its pharmacological effect is improving cereb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Aging Neurosci
Autors principals: Wang, Xiaowan, Song, Runmin, Lu, Wenliang, Liu, Ziyu, Wang, Lichun, Zhu, Xiaojuan, Liu, Yanjun, Sun, Zijie, Li, Jiang, Li, Xiaomeng
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Neuroscience
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5440527/
https://ncbi.nlm.nih.gov/pubmed/28603494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2017.00157
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars